Phase Holographic Imaging PHI AB

Equities

PHI

SE0005504636

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET Other stock markets 23:00:00 30/01/2024 GMT			5-day change	1st Jan Change
6.46 ^SEK	-4.44%		-.--%	+8.39%

06-26	Phase Holographic Imaging PHI AB Reports Earnings Results for the Fourth Quarter Ended April 30, 2024	CI
06-19	Phase Holographic Imagin Grows Its Network of Collaborations	CI

Phase Holographic Imaging PHI AB Reports Earnings Results for the Fourth Quarter Ended April 30, 2024

June 26, 2024 at 07:04 am

Phase Holographic Imaging PHI AB (publ) reported earnings results for the fourth quarter ended April 30, 2024. For the fourth quarter, the company reported sales was SEK 1.69 million compared to SEK 1.87 million a year ago. Net loss was SEK 5.35 million compared to SEK 7.72 million a year ago.

Latest news about Phase Holographic Imaging PHI AB

Phase Holographic Imaging PHI AB Reports Earnings Results for the Fourth Quarter Ended April 30, 2024	06-26	CI
Phase Holographic Imagin Grows Its Network of Collaborations	06-19	CI
Phase Holographic Imaging Bolsters Nordic Sales Presence with New Distribution Agreement Between Altium and Kem-En-Tec Nordic	06-18	CI
Sweden-based PHI Plots Iberian Expansion with Distribution Subcontract Deal	06-13	MT
Phase Holographic Imaging Phi AB Expands to Spanish and Portuguese Markets Through Altium's New Subcontract with Paralab	06-13	CI
Phase Holographic Imaging Partners with University College London to Use HoloMonitor in First Clinical Research Project	06-11	CI
Phase Holographic Imaging Obtains SEK7 Million Loan Agreement	05-17	MT
Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	03-27	CI
Phase Holographic Imaging PHI AB Appoints Ivan Jurkovic as Ordinary Board Member	03-14	CI
Phase Holographic Imaging Presents a Comprehensive Opinion Piece Delivering the Versability and Potential the Company sees for Quantitative Phase Imaging Technology in Regenerative Medicine	03-11	CI
Phase Holographic Imaging Reports Sales Results for the Third Quarter of 2024	01-30	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	12-21	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the First Quarter Ended July 31, 2023	20/09/23	CI
European Patent Office Intends to Grant Phase Holographic Imaging AB Patent on Synthetic Antibodies	04/07/23	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2023	26/06/23	CI
Phase Holographic Imaging Phi AB Elects Goran Dubravcic Elected as A New Member of the Board	09/05/23	CI
Altium Mitkap AG acquired a 11.8% stake in Phase Holographic Imaging PHI AB from Formue Nord A/S.	07/03/23	CI
PHI expands its global network to India	24/01/23	CI
Phase Holographic Imaging Announces Management Changes	17/01/23	CI
Phase Holographic Imaging PHI AB Announces Management Changes	17/01/23	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	21/12/22	CI
Phase Holographic Imaging Announces Opening A New Development Office in the U.S	21/11/22	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the First Quarter Ended July 31, 2022	29/09/22	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2022	29/06/22	CI
PHI Enters Biomanufacturing Partnership with Wake Forest Institute for Regenerative Medicine	06/04/22	CI

Chart Phase Holographic Imaging PHI AB

Duration

Period

More charts

Company Profile

Phase Holographic Imaging PHI AB (PHI) is a Sweden-based company active in the field of medical technology. It develops and markets time-lapse cytometers for clinical applications. The products use holographic microscopy technology, with image sensors capturing light information from objects, and computer processing the information to create visual image. It is also engaged in the development of related software. Its method allows to view and measure living cell over time, without disturbing or destroying it. PHI collaborates with cancer- and stem cell researchers, among others. The Companyâs product portfolio includes HoloMonitor M3, a bench-top time-lapse cytometer, and HoloMonitor M4, allowing cell analysis in the cultivation incubator.

Sector

Advanced Medical Equipment & Technology

Calendar

24/09/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
PHASE HOLOGRAPHIC IMAGING PHI AB	+8.39%	15.96M
SARTORIUS AG	-34.27%	14.75B
QUIDELORTHO CORPORATION	-54.93%	2.22B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+15.49%	1.82B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-14.07%	1.43B
BIOTAGE AB	+21.99%	1.23B
REVENIO GROUP OYJ	+1.25%	784M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-35.50%	741M
CONTEC MEDICAL SYSTEMS CO.,LTD	-36.65%	723M
VAREX IMAGING CORPORATION	-28.15%	602M

Medical Diagnostic & Testing Equipment